We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Vishal Verma - Principal Scientist, Discovery Chemistry

Vishal Verma

Principal Scientist, Discovery Chemistry

"I’m motivated by working with a highly talented, multi-disciplinary group of scientists extremely focused on taking on the toughest challenges in the discovery for transformational therapies."
10
Years at Genentech
11
Publications at Genentech

I joined Genentech in 2012 after spending 4 years at Schering-Plough/Merck working on multiple virology programs. I received my PhD in 2008 from Stanford working with Paul Wender on natural product analog design and synthesis. During my PhD, it was extremely satisfying taking complex compounds I had synthesized myself and running biochemical and cellular assays to evaluate their activity.  This training prepared me extremely well for a career in medicinal chemistry.

Featured Publication

Discovery of Inhibitors of the LPS transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-negative Activity.

J. Med. Chem., 2022, 65, 4085-4120.

Verma, V.; Wang L.; Labadie, S.; Liang, J.; Sellers, B.; Wang, J.; Dong, L.; Qiuyue, W.; Zhang, S.; Xu, Z.; Zhang, Y.; Niu, Y.; Wang, X.; Wai, J.; Koehler, M. F. T.; Hu, H.; Alexander, M. K.; Nishiyama, M.; Niu, A.; Xu, Y.; Pangg, J.; Katakam, A. K.; Reichelt, M.; Austin, C. A.; Ho, H.; Payandeh, J.; Koth, C. M.

"Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients"

J. Med. Chem., 2020, 63, 14357–14381.

Gampe, C. M.; Verma. V. A.